Combination menopausal hormone therapy ups heart disease risk
February 17th, 2010 - 5:02 pm ICT by ANIWashington, Feb 17 (ANI): Combination hormone therapy increases the risk of heart disease in healthy postmenopausal women, new analyses from the Women’s Health Initiative (WHI) have confirmed.
Researchers from the Harvard School of Public Health and the National Heart, Lung and Blood Institute re-analyzed data from the landmark Women’s Health Initiative clinical trial of the effects of combination hormone therapy — progestin in combination with estrogen — in 16,608 post-menopausal women with an intact uterus, ages 50-79 years at enrollment.
The study found a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause.
“Today, most women who take hormone therapy for menopausal symptoms begin therapy shortly after menopause. Based on today’s report, even these women appear to be at increased risk of heart disease for several years after starting combination hormone therapy,” Dr. Susan B. Shurin, acting director of the National Heart, Lung, and Blood Institute, said in a statement.
“It is clearer than ever that women who are considering post-menopausal hormone therapy for menopausal symptoms should discuss their risk of heart disease and other risks — such as breast cancer, stroke, and dangerous blood clots — with their doctors before starting therapy,” she added.
The study is published in the Feb. 16, 2010, Annals of Internal Medicine. (ANI)
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Estrogen therapy 'ups kidney stones risk' in postmenopausal women - Oct 12, 2010
- HRT raises risk of kidney stones - Oct 13, 2010
- Postmenopausal hormone therapy 'ups breast cancer risk' - Oct 20, 2010
- Hormone replacement therapy 'increases lung cancer risk' - Mar 04, 2010
- Estrogen not linked to lung cancer mortality in postmenopausal women - Aug 14, 2010
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Postmenopausal smoking boosts sex hormone levels - Sep 01, 2011
- New scientific statement weighs pros and cons of menopausal hormone therapy - Jun 23, 2010
- Menopausal hormone therapy 'ups ovarian cancer risk' - Nov 10, 2010
- Hormone-replacement therapy 'ups risk of dying from lung cancer' - Sep 20, 2009
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Hormone replacement therapy 'beneficial for postmenopausal women' - Oct 05, 2009
- Menopausal hot flashes 'may protect women's hearts' - Feb 25, 2011
Tags: annals of internal medicine, breast cancer, dangerous blood clots, dr susan, estrogen, harvard school of public health, health initiative, heart disease, heart disease risk, hormone therapy, intact uterus, menopausal symptoms, national heart lung, national heart lung and blood institute, post menopausal, postmenopausal women, progestin, risk of heart disease, school of public health, whi